US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lexaria Bioscience Corp

1.17

-0.0500-4.10%

Pre-market: 1.180.0100+0.85%09:08 EDT

Volume:90.89K

Turnover:107.67K

Market Cap:22.88M

PE:-1.99

High:1.24

Open:1.21

Low:1.16

Close:1.22

Loading ...

Overview Company News Filings

Lexaria Releases Annual Letter from the CEO

ACCESS Newswire

LEXX: IRB Approval Clears Way for GLP-1 Study #5

Zacks Small Cap Research

Lexaria Bioscience Is Maintained at Buy by HC Wainwright & Co.

Lexaria Bioscience price target lowered to $7 from $10 at H.C. Wainwright

BRIEF-Lexaria Bioscience Corp Files For Mixed Shelf Of Up To $50 Million - SEC Filing

Lexaria Bioscience Corp Files for Mixed Shelf of up to $50 Mln - SEC Filing

THOMSON REUTERS

Lexaria Bioscience Receives Ethics Board Approval for Oral Liraglutide Pilot Study

MT Newswires Live

Lexaria’s human GLP-1 study 5 receives IRB approval

Lexaria Bioscience Corp: Co's Human Glp-1 Study #5 Receives Independent Review Board Approval

THOMSON REUTERS

Lexaria’s Human GLP-1 Study #5 Receives Independent Review Board Approval

Lexaria Bioscience Says Oral DehydraTECH-Tirzepatide Causes Fewer Adverse Effects

MT Newswires Live

Lexaria Bioscience announces partial results from GLP-1-H24-3 study

Lexaria's Oral DehydraTECH-Tirzepatide Reduces Side Effects by Half with Comparable Efficacy Versus Eli Lilly's Injectable GLP-1/GIP Drug Zepbound(R)

Lexaria Bioscience First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

Lexaria Bioscience Corp reports results for the quarter ended November 30 - Earnings Summary

Lexaria Bioscience Corp expected to post a loss of 12 cents a share - Earnings Preview

Lexaria Bioscience’s Phase 1b study starts patient dosing, says H.C. Wainwright

Lexaria Bioscience Initiates Promising Drug Study

Lexaria Bioscience begins dosing for GLP-1 study #4

Lexaria's Registered GLP-1 Study #4 Begins Dosing

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/LEXX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LEXX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LEXX\",,,,,undefined,":{"symbol":"LEXX","market":"US","secType":"STK","nameCN":"Lexaria Bioscience Corp","latestPrice":1.17,"timestamp":1745956800000,"preClose":1.22,"halted":0,"volume":90891,"hourTrading":{"tag":"盘前","latestPrice":1.18,"preClose":1.17,"latestTime":"09:08 EDT","volume":430,"amount":510.10018499999995,"timestamp":1746018505179},"delay":0,"floatShares":17696600,"shares":19559200,"eps":-0.588992,"marketStatus":"Pre-Mkt","change":-0.05,"latestTime":"04-30 09:21:50 EDT","open":1.21,"high":1.24,"low":1.16,"amount":107674.8593472,"amplitude":0.065574,"askPrice":1.2,"askSize":200,"bidPrice":1.01,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.588992,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1746019800000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":1.17,"preHourTrading":{"tag":"盘前","latestPrice":1.18,"preClose":1.17,"latestTime":"09:08 EDT","volume":430,"amount":510.10018499999995,"timestamp":1746018505179},"postHourTrading":{"tag":"盘后","latestPrice":1.1699,"preClose":1.17,"latestTime":"19:31 EDT","volume":2328,"amount":2682.97,"timestamp":1745969469451},"volumeRatio":0.4865633132089562},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LEXX\",,,,,undefined,":{"symbol":"LEXX","floatShares":17696600,"roa":"-77.60%","roe":"-145.55%","lyrEps":-0.467971,"volumeRatio":0.4865633132089562,"shares":19559200,"dividePrice":0,"high":1.24,"amplitude":0.065574,"preClose":1.22,"low":1.16,"week52Low":1.15,"pbRate":"3.20","psRate":"43.51","week52High":4.44,"institutionHeld":0,"latestPrice":1.17,"committee":-0.333333,"eps":-0.588992,"divideRate":0,"volume":90891,"delay":0,"ttmEps":-0.588992,"open":1.21,"prevYearClose":2.1,"prevWeekClose":1.35,"prevMonthClose":1.71,"prevQuarterClose":1.71,"fiveDayClose":1.46,"twentyDayClose":1.71,"sixtyDayClose":1.77},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LEXX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2507215886","title":"Lexaria Releases Annual Letter from the CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2507215886","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507215886?lang=en_us&edition=fundamental","pubTime":"2025-01-30 22:15","pubTimestamp":1738246500,"startTime":"0","endTime":"0","summary":"KELOWNA, BC / ACCESS Newswire / January 30, 2025 / Lexaria Bioscience Corp. , , a global innovator in drug delivery platforms is pleased to provide this annual letter from its Chief Executive Officer  Richard Christopher as a strategic update to all stakeholders.In 2024, Lexaria made the course changing commitment to becoming an oral based drug delivery enabling technology company focused on one of the largest and fastest growing drug sectors in the world today - GLP-1. To that end, we conducted a series of human and animal studies which produced extremely encouraging pharmacokinetic, weight, blood glucose, insulin, and safety results. The success of these studies is a true testament to the effectiveness, versatility, and promise of our proprietary DehydraTECHTM technology platform within, and outside of, GLP-1.2024 R&D ResultsIn 2024, Lexaria spent virtually all of its time and efforts on conducting a series of human and animal studies which utilized our DehydraTECH technology with th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lexaria-releases-annual-letter-ceo-141500696.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LEXXW","BK4581","BK4557","XBI","BK4588","LEXX","BK4007","ACB","BK4585"],"gpt_icon":0},{"id":"2506512605","title":"LEXX: IRB Approval Clears Way for GLP-1 Study #5","url":"https://stock-news.laohu8.com/highlight/detail?id=2506512605","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506512605?lang=en_us&edition=fundamental","pubTime":"2025-01-28 17:47","pubTimestamp":1738057620,"startTime":"0","endTime":"0","summary":"Lexaria Bioscience Corporation  reported fiscal first quarter 2025 results along with program updates, progress in its GLP-1 trials, a capital raise and final preparations for the Phase Ib trial evaluating DehydraTECH in obese patients. Several new patents were granted bringing the corporate total to 43.So far, Lexaria has been able to achieve impressive bioavailability and reach therapeutic drug levels in the blood plasma faster while reducing side effects using DehydraTECH formulations of the leading GLP-1 agonists compared with their approved infused formulations. With sponsors seeking the next generation of weight loss products and opportunities for life cycle management, Lexaria’s DehydraTECH formulations provide an answer. As the company continues its third and fourth human study in the class and prepares to launch its fifth, management is reaching out to potential partners who may be interested in further analysis and licensing opportunities.Research and development expenses tot","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lexx-irb-approval-clears-way-094700718.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","LEXX","LEXXW","DHT","GLP","BK4144","BK4590"],"gpt_icon":0},{"id":"2505511508","title":"Lexaria Bioscience Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2505511508","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505511508?lang=en_us&edition=fundamental","pubTime":"2025-01-24 20:26","pubTimestamp":1737721560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LEXX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 24, 2025 07:26 ET (12:26 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEXX"],"gpt_icon":0},{"id":"2505853837","title":"Lexaria Bioscience price target lowered to $7 from $10 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2505853837","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505853837?lang=en_us&edition=fundamental","pubTime":"2025-01-24 19:10","pubTimestamp":1737717057,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Yi Chen lowered the firm’s price target on Lexaria Bioscience (LEXX) to $7 from $10 and keeps a Buy rating on the shares. T...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lexaria-bioscience-price-target-lowered-to-7-from-10-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lexaria-bioscience-price-target-lowered-to-7-from-10-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LEXX"],"gpt_icon":0},{"id":"2505701444","title":"BRIEF-Lexaria Bioscience Corp Files For Mixed Shelf Of Up To $50 Million - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2505701444","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505701444?lang=en_us&edition=fundamental","pubTime":"2025-01-23 05:51","pubTimestamp":1737582716,"startTime":"0","endTime":"0","summary":"BRIEF-Lexaria Bioscience Corp Files For Mixed Shelf Of Up To $50 Million - SEC FilingLexaria Bioscience Corp LEXX.O:LEXARIA BIOSCIENCE CORP FILES FOR MIXED SHELF OF UP TO $50 MILLION - SEC FILINGSource text: [ID:n0001640334-25-000146]Further company coverage: LEXX.O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250122:nFWN3OI14G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LEXX"],"gpt_icon":0},{"id":"2505063327","title":"Lexaria Bioscience Corp Files for Mixed Shelf of up to $50 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2505063327","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505063327?lang=en_us&edition=fundamental","pubTime":"2025-01-23 05:07","pubTimestamp":1737580025,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250122:nFWN3OI14G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LEXX"],"gpt_icon":0},{"id":"2503968625","title":"Lexaria Bioscience Receives Ethics Board Approval for Oral Liraglutide Pilot Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2503968625","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503968625?lang=en_us&edition=fundamental","pubTime":"2025-01-15 23:36","pubTimestamp":1736955371,"startTime":"0","endTime":"0","summary":"Lexaria Bioscience  said Wednesday it received the independent ethics board approval to initiate a human pilot study to compare an oral version of liraglutide with the conventional injected method.The company said the oral version is formulated using DehydraTECH-processing and the pilot study will focus on safety and pharmacokinetic performance in humans.Novo Nordisk markets liraglutide's injectable form as Saxenda and Victoza for weight loss and treatment of diabetes.Shares of Lexaria were up over 6% in recent trading.Price: 2.06, Change: +0.13, Percent Change: +6.94","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","LEXX"],"gpt_icon":0},{"id":"2503642736","title":"Lexaria’s human GLP-1 study 5 receives IRB approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2503642736","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503642736?lang=en_us&edition=fundamental","pubTime":"2025-01-15 22:30","pubTimestamp":1736951427,"startTime":"0","endTime":"0","summary":"Lexaria Bioscience (LEXX) it has received the necessary independent ethics board approval required for its contract research organization to begin ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lexarias-human-glp-1-study-5-receives-irb-approval?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lexarias-human-glp-1-study-5-receives-irb-approval?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4144","BK4007","BK4590","LEXX","GLP"],"gpt_icon":0},{"id":"2503642884","title":"Lexaria Bioscience Corp: Co's Human Glp-1 Study #5 Receives Independent Review Board Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2503642884","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503642884?lang=en_us&edition=fundamental","pubTime":"2025-01-15 22:27","pubTimestamp":1736951266,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250115:nFWN3OB0YQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LEXX","BK4007"],"gpt_icon":0},{"id":"2503628951","title":"Lexaria’s Human GLP-1 Study #5 Receives Independent Review Board Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2503628951","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503628951?lang=en_us&edition=fundamental","pubTime":"2025-01-15 22:20","pubTimestamp":1736950800,"startTime":"0","endTime":"0","summary":"Positive results in a recent animal study strongly supports first-ever human investigation for DehydraTECH-liraglutide in an oral capsule format. KELOWNA, BC / ACCESSWIRE / January 15, 2025 / Lexaria Bioscience Corp.  , a global innovator in drug delivery platforms, is pleased to announce that it has received the necessary independent ethics board approval required for its contract research organization  to begin to implement and execute human pilot study GLP-1-H25-5 . The Study will compare an oral version of liraglutide, formulated from the DehydraTECH-processing of Saxenda  to the conventional injected liraglutide .The Study protocol design is complete and a clinical test site has been d","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lexaria-human-glp-1-study-142000335.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4590","LEXX","LEXXW","BK4144","GLP"],"gpt_icon":0},{"id":"2503574159","title":"Lexaria Bioscience Says Oral DehydraTECH-Tirzepatide Causes Fewer Adverse Effects","url":"https://stock-news.laohu8.com/highlight/detail?id=2503574159","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503574159?lang=en_us&edition=fundamental","pubTime":"2025-01-14 22:59","pubTimestamp":1736866783,"startTime":"0","endTime":"0","summary":"Lexaria Bioscience  said Tuesday that an oral form of tirzepatide processed through its DehydraTECH drug delivery platform caused 47% fewer adverse events than Eli Lilly's  injectable Zepbound.The company said partial final results of its study comparing the two versions showed that the oral DehydraTECH-tirzepatide version produced 20 adverse events compared with the injection's 38 adverse events.Both versions produced \"similarly increased levels of insulin from baseline\" at the end of the eight-day study of nine participants, while blood glucose reductions from each version were comparable, Lexaria Bioscience added.Additional results from the study are still undergoing analysis and the company said it plans to add a fifth arm to evaluate DehydraTECH-tirzepatide in an oral capsule.Shares of Lexaria Bioscience were down more than 11% in early Tuesday trading.Price: 1.87, Change: -0.19, Percent Change: -9.22","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BJLML261.HKD","LU1551013425.SGD","LU1061106388.HKD","LU2211815571.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","SG9999018865.SGD","LEXX","LLY","BK4585","LU0058720904.USD","LU0385154629.USD","BK4581","LU0238689110.USD","SG9999014914.USD","LU1804176565.USD","SG9999017495.SGD","SG9999015986.USD","SG9999001176.USD","SG9999001176.SGD","IE0002141913.USD","LU1035775433.USD","LU0417517546.SGD","LU2491050071.SGD","LU0708995401.HKD","BK4599","LU2265009873.SGD","LU1127390331.HKD","SG9999013999.USD","SGXZ81514606.USD","LU0256863811.USD","LU0640476718.USD","LU0820561818.USD","LU0882574139.USD","IE0004445239.USD","LU1868836591.USD","LU2361044949.HKD","SG9999014880.SGD","LU2237443382.USD","LU2491050154.USD","LU2106854487.HKD","LU2089984988.USD","LU0289739699.SGD","LU2023250504.SGD","SGXZ57979304.SGD","LU0094547139.USD","LU1366192091.USD","LU0079474960.USD","SG9999018857.SGD","LU2112291526.USD"],"gpt_icon":1},{"id":"2503249579","title":"Lexaria Bioscience announces partial results from GLP-1-H24-3 study","url":"https://stock-news.laohu8.com/highlight/detail?id=2503249579","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503249579?lang=en_us&edition=fundamental","pubTime":"2025-01-14 22:20","pubTimestamp":1736864430,"startTime":"0","endTime":"0","summary":"Lexaria Bioscience (LEXX) announces partial final results showcasing the tolerability and glycemic control efficacy findings from human study GLP-1...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lexaria-bioscience-announces-partial-results-from-glp-1-h24-3-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lexaria-bioscience-announces-partial-results-from-glp-1-h24-3-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLP","LEXX","BK4144","BK4007","BK4590"],"gpt_icon":0},{"id":"2503579396","title":"Lexaria's Oral DehydraTECH-Tirzepatide Reduces Side Effects by Half with Comparable Efficacy Versus Eli Lilly's Injectable GLP-1/GIP Drug Zepbound(R)","url":"https://stock-news.laohu8.com/highlight/detail?id=2503579396","media":"ACCESSWIRE","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503579396?lang=en_us&edition=fundamental","pubTime":"2025-01-14 22:10","pubTimestamp":1736863800,"startTime":"0","endTime":"0","summary":"Oral DehydraTECH-tirzepatide evidenced reduced adverse events of 47% compared to injected Zepbound. Blood glucose reduction and insulin secretion levels from the oral DehydraTECH-tirzepatide were comparable to injected Zepbound. KELOWNA, BC / ACCESSWIRE / January 14, 2025 / Lexaria Bioscience Corp.  , a global innovator in drug delivery platforms, announces partial final results showcasing the tolerability and glycemic control efficacy findings from human study GLP-1-H24-3 , comparing an oral version of DehydraTECH-processed Zepbound  to conventional injected Zepbound.\"Lexaria is delighted, in our first-ever attempt to render a competitive version of an orally deliverable tirzepatide formulation, to have already achieved approximate parity in effectiveness with apparent superiority in tolerability to the advanced commercial, injected version of Zepbound already on the market,\" said Richard Christopher, CEO of Lexaria. \"We plan to continue to optimize dosing","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lexarias-oral-dehydratech-tirzepatide-reduces-141000300.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0122379950.USD","BK4144","LU1093756325.SGD","LU0882574055.USD","LU0289739699.SGD","LLY","LU0823416689.USD","IE00B1BXHZ80.USD","LU0079474960.USD","LU0061475181.USD","LU1623119135.USD","LU2361044865.SGD","LU2264538146.SGD","LU0320765059.SGD","SG9999013999.USD","LU1267930730.SGD","LEXXW","SG9999014898.SGD","LU1023059063.AUD","LU2602419157.SGD","BK4581","SGXZ57979304.SGD","SGXZ81514606.USD","LU1868836757.USD","SGXZ31699556.SGD","SGXZ99366536.SGD","LU2237443978.SGD","SG9999015945.SGD","IE00BJJMRZ35.SGD","LU0385154629.USD","LU1868836914.USD","LU2265009873.SGD","LU1291159041.SGD","IE00BJLML261.HKD","R","LU0471298777.SGD","IE0002141913.USD","LU1069344957.HKD","GLP","LU0058720904.USD","LU0417517546.SGD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","BK4599","LEXX","LU0256863902.USD","LU2461242641.AUD","LU2324357040.USD","LU2106854487.HKD","SG9999017495.SGD"],"gpt_icon":1},{"id":"2503239375","title":"Lexaria Bioscience First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags","url":"https://stock-news.laohu8.com/highlight/detail?id=2503239375","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503239375?lang=en_us&edition=fundamental","pubTime":"2025-01-14 18:49","pubTimestamp":1736851786,"startTime":"0","endTime":"0","summary":"NasdaqCM:LEXX Earnings and Revenue History January 14th 2025. All figures shown in the chart above are for the trailing 12 month  period. Revenue exceeded analyst estimates by 84%. Earnings per share  missed analyst estimates by 33%.Looking ahead, revenue is forecast to grow 71% p.a. on average during the next 3 years, compared to a 9.0% growth forecast for the Pharmaceuticals industry in the US.The company's shares are down 5.5% from a week ago.Before you take the next step you should know about the 4 warning signs for Lexaria Bioscience (2 are significant!","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lexaria-bioscience-first-quarter-2025-104946203.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LEXX","LEXXW"],"gpt_icon":0},{"id":"2502848196","title":"Lexaria Bioscience Corp reports results for the quarter ended November 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2502848196","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502848196?lang=en_us&edition=fundamental","pubTime":"2025-01-11 06:01","pubTimestamp":1736546494,"startTime":"0","endTime":"0","summary":"Lexaria Bioscience Corp reports results for the quarter ended November 30 - Earnings SummaryLexaria Bioscience Corp LEXX.OQ reported a quarterly adjusted loss of 16 cents per share for the quarter end","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250110:nL8N3O622Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEXX"],"gpt_icon":0},{"id":"2502240088","title":"Lexaria Bioscience Corp  expected to post a loss of 12 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2502240088","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502240088?lang=en_us&edition=fundamental","pubTime":"2025-01-09 05:03","pubTimestamp":1736370194,"startTime":"0","endTime":"0","summary":"Lexaria Bioscience Corp  expected to post a loss of12cents a share - Earnings Preview Lexaria Bioscience Corp LEXX.OQ LEXX.O is expected to report resultson January 10 (estimated) for the period endin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nL8N3O41Q9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEXX"],"gpt_icon":0},{"id":"2493425872","title":"Lexaria Bioscience’s Phase 1b study starts patient dosing, says H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2493425872","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493425872?lang=en_us&edition=fundamental","pubTime":"2024-12-21 00:20","pubTimestamp":1734711613,"startTime":"0","endTime":"0","summary":"H.C. Wainwright reiterates a Buy rating and $10 price target on Lexaria Bioscience (LEXX) shares after the company announced that the Phase 1b 12-w...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lexaria-biosciences-phase-1b-study-starts-patient-dosing-says-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lexaria-biosciences-phase-1b-study-starts-patient-dosing-says-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LEXX","BK4007"],"gpt_icon":0},{"id":"2492105618","title":"Lexaria Bioscience Initiates Promising Drug Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2492105618","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492105618?lang=en_us&edition=fundamental","pubTime":"2024-12-20 00:14","pubTimestamp":1734624862,"startTime":"0","endTime":"0","summary":"Lexaria Bioscience (LEXX) has released an update. Lexaria Bioscience has launched a 12-week Phase 1b study to assess if its DehydraTECH technology ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lexaria-bioscience-initiates-promising-drug-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lexaria-bioscience-initiates-promising-drug-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LEXX"],"gpt_icon":0},{"id":"2492173179","title":"Lexaria Bioscience begins dosing for GLP-1 study #4","url":"https://stock-news.laohu8.com/highlight/detail?id=2492173179","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492173179?lang=en_us&edition=fundamental","pubTime":"2024-12-19 22:21","pubTimestamp":1734618076,"startTime":"0","endTime":"0","summary":"Lexaria Bioscience (LEXX) has begun dosing in the Company’s Phase 1b, 12-week chronic study GLP-1-H24-4. The Study is designed mainly to determine ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lexaria-bioscience-begins-dosing-for-glp-1-study-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lexaria-bioscience-begins-dosing-for-glp-1-study-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4590","LEXX","GLP","BK4007","BK4144"],"gpt_icon":0},{"id":"2492171671","title":"Lexaria's Registered GLP-1 Study #4 Begins Dosing","url":"https://stock-news.laohu8.com/highlight/detail?id=2492171671","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492171671?lang=en_us&edition=fundamental","pubTime":"2024-12-19 22:05","pubTimestamp":1734617100,"startTime":"0","endTime":"0","summary":"Registered Phase-1b 12-week study will investigate safety, diabetes control, and weight loss. KELOWNA, BC / ACCESSWIRE / December 19, 2024 / Lexaria Bioscience Corp.  , a global innovator in drug delivery platforms, announces it has begun dosing in the Company's Phase 1b, 12-week chronic study GLP-1-H24-4, . The Study is designed mainly to determine whether Lexaria's proprietary DehydraTECH technology improves the safety and effectiveness of existing GLP-1 drugs.\"Achieving the first patient, first dose Study milestone is a critical achievement,\" said John Docherty, President and Chief Scientific Officer of Lexaria Bioscience Corp. \"The world's first 12-week human study evaluating DehydraTECH-processed GLP-1 drugs, in addition to DehydraTECH-CBD, in pre-diabetics or diabetic patients is underway. Potential benefits of reduced side-effects and improved efficacy could be evidenced.\". Arm 1 of the Study will utilize a proprietary, patented DehydraTECH-CBD formulation. Our 2022 diabetes ani","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/FJePO2ijjHG5xb7IgCEAtw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/125bab67eda29e558483e26b3c7ebbdc","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/FJePO2ijjHG5xb7IgCEAtw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/125bab67eda29e558483e26b3c7ebbdc"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lexarias-registered-glp-1-study-140500420.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GLP","LEXX","ACB","IE00BMPRXN33.USD","BK4585","IE00BMPRXR70.SGD","BK4144","LU0348723411.USD","IE00BMPRXQ63.HKD","BK4007","LEXXW","BK4557","BK4141","BK4588","BK4590"],"gpt_icon":1}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":76,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LEXX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-04-14","symbol":"LEXX","fiscalQuarterEnding":"2025/02","expectedEps":-0.16,"name":null,"time":"","type":"earning","dateTimestamp":1744603200000,"reportTimeType":"","actualEps":-0.15},{"market":"US","date":"2025-01-10","symbol":"LEXX","fiscalQuarterEnding":"2024/11","expectedEps":-0.12,"name":null,"time":"","type":"earning","dateTimestamp":1736485200000,"reportTimeType":"","actualEps":-0.16},{"market":"US","date":"2024-11-26","symbol":"LEXX","fiscalQuarterEnding":"2024/08","expectedEps":-0.11,"name":null,"time":"","type":"earning","dateTimestamp":1732597200000,"reportTimeType":"","actualEps":-0.15},{"market":"US","date":"2024-07-12","symbol":"LEXX","fiscalQuarterEnding":"2024/05","expectedEps":-0.09,"name":null,"time":"","type":"earning","dateTimestamp":1720756800000,"reportTimeType":"","actualEps":-0.13},{"market":"US","date":"2024-04-09","symbol":"LEXX","fiscalQuarterEnding":"2024/02","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1712635200000,"reportTimeType":"post","actualEps":-0.06}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LEXX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LEXX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1720670400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LEXX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LEXX","date":"2025-04-29","current":-2.28299,"percent":0.772059,"low":-15.58291,"twenty":-8.674369,"median":-4.895701,"eighty":-2.120821,"high":-0.671866,"avg":-5.444138,"sd":3.500221,"marketCap":21422198},"quantilePoints":[{"date":"2020-05-01","current":-5.561251,"twenty":-33.125317,"median":-14.47305,"eighty":-9.432656,"marketCap":22844005},{"date":"2020-05-08","current":-6.179172,"twenty":-32.823087,"median":-14.344381,"eighty":-9.374504,"marketCap":25382246},{"date":"2020-05-15","current":-6.01942,"twenty":-32.672527,"median":-14.287498,"eighty":-9.273795,"marketCap":24726033},{"date":"2020-05-22","current":-7.153514,"twenty":-32.415471,"median":-14.252578,"eighty":-9.187013,"marketCap":29384559},{"date":"2020-05-29","current":-6.4338,"twenty":-32.157144,"median":-14.181035,"eighty":-9.072999,"marketCap":26428185},{"date":"2020-06-05","current":-6.324753,"twenty":-31.804453,"median":-13.944684,"eighty":-8.999523,"marketCap":25980250},{"date":"2020-06-12","current":-6.148096,"twenty":-31.465594,"median":-13.914538,"eighty":-8.923481,"marketCap":25254596},{"date":"2020-06-19","current":-6.324753,"twenty":-30.601154,"median":-13.785281,"eighty":-8.848785,"marketCap":25980250},{"date":"2020-06-26","current":-6.416353,"twenty":-30.314716,"median":-13.710418,"eighty":-8.718288,"marketCap":26356516},{"date":"2020-07-02","current":-6.302912,"twenty":-30.266598,"median":-13.635945,"eighty":-8.622031,"marketCap":26387871},{"date":"2020-07-10","current":-5.274717,"twenty":-30.090965,"median":-13.515269,"eighty":-8.509786,"marketCap":22083213},{"date":"2020-07-17","current":-6.668826,"twenty":-29.924956,"median":-13.437166,"eighty":-8.299061,"marketCap":27919812},{"date":"2020-07-24","current":-8.152808,"twenty":-29.075663,"median":-13.385222,"eighty":-8.158998,"marketCap":34132676},{"date":"2020-07-31","current":-8.470574,"twenty":-28.457121,"median":-13.361425,"eighty":-8.220324,"marketCap":35463042},{"date":"2020-08-07","current":-8.603064,"twenty":-26.842905,"median":-13.278159,"eighty":-8.246704,"marketCap":36017724},{"date":"2020-08-14","current":-7.957834,"twenty":-26.102655,"median":-13.200237,"eighty":-8.10478,"marketCap":33316394},{"date":"2020-08-21","current":-6.828681,"twenty":-25.613742,"median":-13.084334,"eighty":-8.025356,"marketCap":28589066},{"date":"2020-08-28","current":-6.909335,"twenty":-25.514175,"median":-13.02723,"eighty":-7.895161,"marketCap":28926732},{"date":"2020-09-04","current":-6.29099,"twenty":-25.31504,"median":-12.988635,"eighty":-7.861968,"marketCap":26337958},{"date":"2020-09-11","current":-5.936114,"twenty":-25.19058,"median":-12.942394,"eighty":-7.794164,"marketCap":24852228},{"date":"2020-09-18","current":-5.699529,"twenty":-25.140796,"median":-12.909408,"eighty":-7.730024,"marketCap":23861739},{"date":"2020-09-25","current":-5.591991,"twenty":-24.991445,"median":-12.877303,"eighty":-7.596477,"marketCap":23411518},{"date":"2020-10-02","current":-5.376914,"twenty":-24.853088,"median":-12.809344,"eighty":-7.462976,"marketCap":22511076},{"date":"2020-10-09","current":-5.582312,"twenty":-24.827228,"median":-12.803082,"eighty":-7.350391,"marketCap":23370998},{"date":"2020-10-16","current":-4.577753,"twenty":-24.791342,"median":-12.753628,"eighty":-7.296625,"marketCap":18008862},{"date":"2020-10-23","current":-4.509086,"twenty":-24.692743,"median":-12.710306,"eighty":-7.191411,"marketCap":17738726},{"date":"2020-10-30","current":-4.102811,"twenty":-24.642959,"median":-12.617531,"eighty":-7.089341,"marketCap":16140441},{"date":"2020-11-06","current":-4.495353,"twenty":-24.60819,"median":-12.591652,"eighty":-6.928477,"marketCap":17684699},{"date":"2020-11-13","current":-4.941684,"twenty":-24.545104,"median":-12.477953,"eighty":-6.871324,"marketCap":19440565},{"date":"2020-11-20","current":-4.701352,"twenty":-24.467575,"median":-12.383388,"eighty":-6.668245,"marketCap":18495100},{"date":"2020-11-27","current":-4.250443,"twenty":-24.417791,"median":-12.383388,"eighty":-6.586708,"marketCap":16721226},{"date":"2020-12-04","current":-6.351632,"twenty":-24.344256,"median":-12.358407,"eighty":-6.542848,"marketCap":24987295},{"date":"2020-12-11","current":-6.500409,"twenty":-24.269581,"median":-12.208151,"eighty":-6.513218,"marketCap":25572582},{"date":"2020-12-18","current":-5.893856,"twenty":-24.250423,"median":-12.111807,"eighty":-6.490324,"marketCap":23186407},{"date":"2020-12-24","current":-6.476376,"twenty":-24.206373,"median":-12.096594,"eighty":-6.469175,"marketCap":25478036},{"date":"2020-12-31","current":-5.706169,"twenty":-24.145121,"median":-12.073372,"eighty":-6.440343,"marketCap":22448045},{"date":"2021-01-08","current":-5.76339,"twenty":-24.082892,"median":-12.032914,"eighty":-6.408854,"marketCap":22673155},{"date":"2021-01-15","current":-6.279787,"twenty":-24.020662,"median":-11.942094,"eighty":-6.363076,"marketCap":23377840},{"date":"2021-01-22","current":-5.841025,"twenty":-24.020662,"median":-11.897503,"eighty":-6.324753,"marketCap":21744454},{"date":"2021-01-29","current":-6.348344,"twenty":-23.987708,"median":-11.799266,"eighty":-6.315751,"marketCap":23633057},{"date":"2021-02-05","current":-9.872155,"twenty":-23.906804,"median":-11.730236,"eighty":-6.323595,"marketCap":36751190},{"date":"2021-02-12","current":-9.556795,"twenty":-23.795122,"median":-11.682441,"eighty":-6.324753,"marketCap":35577194},{"date":"2021-02-19","current":-9.460815,"twenty":-23.771743,"median":-11.640151,"eighty":-6.324753,"marketCap":35219890},{"date":"2021-02-26","current":-8.199373,"twenty":-23.771743,"median":-11.551652,"eighty":-6.338908,"marketCap":30523905},{"date":"2021-03-05","current":-7.472673,"twenty":-23.697068,"median":-11.526163,"eighty":-6.350317,"marketCap":27818609},{"date":"2021-03-12","current":-8.720404,"twenty":-23.572608,"median":-11.512737,"eighty":-6.355133,"marketCap":32463551},{"date":"2021-03-19","current":-8.281641,"twenty":-23.448149,"median":-11.410887,"eighty":-6.360832,"marketCap":30830165},{"date":"2021-03-26","current":-7.362982,"twenty":-23.311037,"median":-11.367864,"eighty":-6.363763,"marketCap":27410262},{"date":"2021-04-01","current":-7.664631,"twenty":-23.161686,"median":-11.265208,"eighty":-6.368341,"marketCap":28533215},{"date":"2021-04-09","current":-7.513807,"twenty":-22.975203,"median":-11.171334,"eighty":-6.375521,"marketCap":27971739},{"date":"2021-04-16","current":-10.69035,"twenty":-22.893692,"median":-11.040265,"eighty":-6.389754,"marketCap":25317486},{"date":"2021-04-23","current":-11.487816,"twenty":-22.828043,"median":-11.033138,"eighty":-6.411854,"marketCap":27206089},{"date":"2021-04-30","current":-10.905881,"twenty":-22.707615,"median":-11.034169,"eighty":-6.417931,"marketCap":25827919},{"date":"2021-05-07","current":-13.492257,"twenty":-22.552041,"median":-11.047392,"eighty":-6.425699,"marketCap":31953118},{"date":"2021-05-14","current":-13.341385,"twenty":-22.400201,"median":-11.099089,"eighty":-6.436417,"marketCap":31595815},{"date":"2021-05-21","current":-12.500813,"twenty":-22.351461,"median":-11.172121,"eighty":-6.446058,"marketCap":29605125},{"date":"2021-05-28","current":-13.1043,"twenty":-22.231879,"median":-11.265208,"eighty":-6.458512,"marketCap":31034338},{"date":"2021-06-04","current":-14.89321,"twenty":-22.149928,"median":-11.367864,"eighty":-6.465205,"marketCap":35270934},{"date":"2021-06-11","current":-14.117297,"twenty":-22.118803,"median":-11.410887,"eighty":-6.469175,"marketCap":33433374},{"date":"2021-06-18","current":-14.634572,"twenty":-22.031695,"median":-11.455486,"eighty":-6.472151,"marketCap":34658414},{"date":"2021-06-25","current":-15.087188,"twenty":-21.904299,"median":-11.502925,"eighty":-6.477978,"marketCap":35730324},{"date":"2021-07-02","current":-14.806997,"twenty":-21.780393,"median":-11.526163,"eighty":-6.487355,"marketCap":35066760},{"date":"2021-07-09","current":-15.58291,"twenty":-21.780393,"median":-11.527325,"eighty":-6.499229,"marketCap":36904320},{"date":"2021-07-16","current":-9.056977,"twenty":-21.678409,"median":-11.528487,"eighty":-6.499229,"marketCap":33280244},{"date":"2021-07-23","current":-9.404254,"twenty":-21.573706,"median":-11.526163,"eighty":-6.500409,"marketCap":34556327},{"date":"2021-07-30","current":-9.637817,"twenty":-21.453183,"median":-11.522549,"eighty":-6.505772,"marketCap":35414565},{"date":"2021-08-06","current":-9.560467,"twenty":-21.332659,"median":-11.488954,"eighty":-6.51288,"marketCap":35130339},{"date":"2021-08-13","current":-8.523977,"twenty":-21.212135,"median":-11.423157,"eighty":-6.524386,"marketCap":31321710},{"date":"2021-08-20","current":-8.988077,"twenty":-21.193975,"median":-11.406136,"eighty":-6.528671,"marketCap":33027067},{"date":"2021-08-27","current":-9.421237,"twenty":-21.072867,"median":-11.284971,"eighty":-6.542848,"marketCap":34618732},{"date":"2021-09-03","current":-9.746108,"twenty":-20.982035,"median":-11.189873,"eighty":-6.542848,"marketCap":35812482},{"date":"2021-09-10","current":-9.544997,"twenty":-20.824181,"median":-11.135597,"eighty":-6.542848,"marketCap":35073494},{"date":"2021-09-17","current":-9.777048,"twenty":-20.724576,"median":-11.078307,"eighty":-6.542848,"marketCap":35926172},{"date":"2021-09-24","current":-10.612428,"twenty":-20.701837,"median":-11.034169,"eighty":-6.558291,"marketCap":38995814},{"date":"2021-10-01","current":-9.869868,"twenty":-20.531178,"median":-10.981495,"eighty":-6.611265,"marketCap":36267243},{"date":"2021-10-08","current":-10.179268,"twenty":-20.488995,"median":-10.949822,"eighty":-6.633734,"marketCap":37404148},{"date":"2021-10-15","current":-10.581488,"twenty":-20.488995,"median":-10.905881,"eighty":-6.655994,"marketCap":38882123},{"date":"2021-10-22","current":-10.194738,"twenty":-20.471658,"median":-10.86231,"eighty":-6.666084,"marketCap":37460993},{"date":"2021-10-29","current":-9.575937,"twenty":-20.436451,"median":-10.830411,"eighty":-6.668536,"marketCap":35187184},{"date":"2021-11-05","current":-9.715167,"twenty":-20.327206,"median":-10.804878,"eighty":-6.791676,"marketCap":35698791},{"date":"2021-11-12","current":-10.148328,"twenty":-20.143564,"median":-10.737922,"eighty":-6.827422,"marketCap":37290457},{"date":"2021-11-19","current":-8.616797,"twenty":-20.02632,"median":-10.690687,"eighty":-6.849445,"marketCap":31662781},{"date":"2021-11-26","current":-8.260987,"twenty":-20.0069,"median":-10.671553,"eighty":-6.863479,"marketCap":30355342},{"date":"2021-12-03","current":-6.840174,"twenty":-19.934586,"median":-10.612428,"eighty":-6.863479,"marketCap":27545422},{"date":"2021-12-10","current":-7.025044,"twenty":-19.741749,"median":-10.596796,"eighty":-6.863479,"marketCap":28289893},{"date":"2021-12-17","current":-6.531754,"twenty":-19.615799,"median":-10.578981,"eighty":-6.826164,"marketCap":26303411},{"date":"2021-12-23","current":-6.191866,"twenty":-19.51938,"median":-10.535078,"eighty":-6.679019,"marketCap":24934681},{"date":"2021-12-31","current":-5.955422,"twenty":-19.356074,"median":-10.473198,"eighty":-6.628639,"marketCap":23982521},{"date":"2022-01-07","current":-6.443087,"twenty":-19.236954,"median":-10.457728,"eighty":-6.542848,"marketCap":25946351},{"date":"2022-01-14","current":-5.152781,"twenty":-19.117133,"median":-10.426788,"eighty":-6.542848,"marketCap":27434100},{"date":"2022-01-21","current":-5.052184,"twenty":-18.967952,"median":-10.401429,"eighty":-6.525243,"marketCap":26898510},{"date":"2022-01-28","current":-4.560379,"twenty":-18.668908,"median":-10.364908,"eighty":-6.502913,"marketCap":24280071},{"date":"2022-02-04","current":-4.392718,"twenty":-18.668908,"median":-10.347469,"eighty":-6.489782,"marketCap":23387422},{"date":"2022-02-11","current":-4.007097,"twenty":-18.667483,"median":-10.341251,"eighty":-6.469175,"marketCap":21334327},{"date":"2022-02-18","current":-4.314476,"twenty":-18.617444,"median":-10.333079,"eighty":-6.440892,"marketCap":22970852},{"date":"2022-02-25","current":-3.889735,"twenty":-18.440095,"median":-10.297161,"eighty":-6.416353,"marketCap":20709473},{"date":"2022-03-04","current":-3.710896,"twenty":-18.35776,"median":-10.259288,"eighty":-6.37702,"marketCap":19757313},{"date":"2022-03-11","current":-3.744429,"twenty":-18.272902,"median":-10.22525,"eighty":-6.357467,"marketCap":19935843},{"date":"2022-03-18","current":-3.107317,"twenty":-18.171071,"median":-10.224763,"eighty":-6.324865,"marketCap":16543774},{"date":"2022-03-25","current":-3.845025,"twenty":-17.891037,"median":-10.197982,"eighty":-6.318961,"marketCap":20471433},{"date":"2022-04-01","current":-3.688542,"twenty":-17.881648,"median":-10.179268,"eighty":-6.279787,"marketCap":19638293},{"date":"2022-04-08","current":-3.39234,"twenty":-17.785381,"median":-10.153858,"eighty":-6.221421,"marketCap":18061278},{"date":"2022-04-14","current":-3.185945,"twenty":-17.768281,"median":-10.122944,"eighty":-6.204693,"marketCap":22792322},{"date":"2022-04-22","current":-2.495518,"twenty":-17.575778,"median":-10.086448,"eighty":-6.185731,"marketCap":17852994},{"date":"2022-04-29","current":-2.312514,"twenty":-17.497699,"median":-10.042063,"eighty":-6.147983,"marketCap":16543774},{"date":"2022-05-06","current":-2.370742,"twenty":-17.489943,"median":-9.984656,"eighty":-6.122035,"marketCap":16960344},{"date":"2022-05-13","current":-1.705271,"twenty":-17.39456,"median":-9.962688,"eighty":-6.105634,"marketCap":12199545},{"date":"2022-05-20","current":-1.671997,"twenty":-17.285936,"median":-9.940712,"eighty":-6.09087,"marketCap":11961505},{"date":"2022-05-27","current":-1.713589,"twenty":-17.264742,"median":-9.93387,"eighty":-6.058044,"marketCap":12259055},{"date":"2022-06-03","current":-1.81341,"twenty":-17.257904,"median":-9.920751,"eighty":-6.023867,"marketCap":12973175},{"date":"2022-06-10","current":-1.988096,"twenty":-17.136229,"median":-9.900808,"eighty":-6.017376,"marketCap":14222885},{"date":"2022-06-17","current":-1.938186,"twenty":-17.051331,"median":-9.885602,"eighty":-5.98861,"marketCap":13865825},{"date":"2022-06-24","current":-2.736752,"twenty":-17.004275,"median":-9.878747,"eighty":-5.959552,"marketCap":19578783},{"date":"2022-07-01","current":-2.295877,"twenty":-16.835329,"median":-9.865791,"eighty":-5.937004,"marketCap":16424754},{"date":"2022-07-08","current":-2.428971,"twenty":-16.675346,"median":-9.823458,"eighty":-5.903478,"marketCap":17376914},{"date":"2022-07-15","current":-2.438392,"twenty":-16.66574,"median":-9.800253,"eighty":-5.868301,"marketCap":17019854},{"date":"2022-07-22","current":-2.387237,"twenty":-16.651735,"median":-9.761578,"eighty":-5.823139,"marketCap":16662794},{"date":"2022-07-29","current":-2.301978,"twenty":-16.589073,"median":-9.747431,"eighty":-5.807068,"marketCap":16067694},{"date":"2022-08-05","current":-2.408551,"twenty":-16.505285,"median":-9.746108,"eighty":-5.766272,"marketCap":16811569},{"date":"2022-08-12","current":-2.796477,"twenty":-16.452472,"median":-9.699697,"eighty":-5.752153,"marketCap":19519273},{"date":"2022-08-19","current":-2.361659,"twenty":-16.36772,"median":-9.668758,"eighty":-5.723569,"marketCap":16484264},{"date":"2022-08-26","current":-2.472495,"twenty":-16.30819,"median":-9.653288,"eighty":-5.719391,"marketCap":17257894},{"date":"2022-09-02","current":-2.544965,"twenty":-16.294271,"median":-9.637817,"eighty":-5.698952,"marketCap":17763729},{"date":"2022-09-09","current":-2.702693,"twenty":-16.238593,"median":-9.622347,"eighty":-5.63867,"marketCap":18864663},{"date":"2022-09-16","current":-2.417077,"twenty":-16.234654,"median":-9.606878,"eighty":-5.600553,"marketCap":16871079},{"date":"2022-09-23","current":-2.105884,"twenty":-16.195923,"median":-9.584217,"eighty":-5.561251,"marketCap":14698965},{"date":"2022-09-30","current":-2.088832,"twenty":-16.194972,"median":-9.568073,"eighty":-5.554352,"marketCap":14579945},{"date":"2022-10-07","current":-1.884212,"twenty":-16.117012,"median":-9.560467,"eighty":-5.500415,"marketCap":13151705},{"date":"2022-10-14","current":-1.798953,"twenty":-16.06593,"median":-9.544081,"eighty":-5.437212,"marketCap":12556605},{"date":"2022-10-21","current":-1.756324,"twenty":-16.055261,"median":-9.518871,"eighty":-5.376914,"marketCap":12259055},{"date":"2022-10-28","current":-1.901263,"twenty":-16.055261,"median":-9.506322,"eighty":-5.316693,"marketCap":13270725},{"date":"2022-11-04","current":-1.853092,"twenty":-16.018697,"median":-9.483058,"eighty":-5.249722,"marketCap":12934494},{"date":"2022-11-11","current":-2.012099,"twenty":-15.999369,"median":-9.465212,"eighty":-5.161838,"marketCap":14044355},{"date":"2022-11-18","current":-1.875686,"twenty":-15.953664,"median":-9.433393,"eighty":-5.052184,"marketCap":13092195},{"date":"2022-11-25","current":-2.020625,"twenty":-15.921079,"median":-9.421237,"eighty":-4.916007,"marketCap":14103865},{"date":"2022-12-02","current":-2.414922,"twenty":-15.800117,"median":-9.406458,"eighty":-4.808471,"marketCap":17554849},{"date":"2022-12-09","current":-2.398631,"twenty":-15.771913,"median":-9.374504,"eighty":-4.781462,"marketCap":17436424},{"date":"2022-12-16","current":-2.193969,"twenty":-15.76565,"median":-9.351067,"eighty":-4.644331,"marketCap":15948674},{"date":"2022-12-23","current":-2.005681,"twenty":-15.66997,"median":-9.282007,"eighty":-4.550807,"marketCap":14579945},{"date":"2022-12-30","current":-2.013867,"twenty":-15.646442,"median":-9.280758,"eighty":-4.497998,"marketCap":14639455},{"date":"2023-01-06","current":-2.202156,"twenty":-15.566057,"median":-9.2003,"eighty":-4.46149,"marketCap":16008184},{"date":"2023-01-13","current":-2.267647,"twenty":-15.371731,"median":-9.154215,"eighty":-4.348865,"marketCap":16484264},{"date":"2023-01-20","current":-2.301829,"twenty":-15.296539,"median":-9.072941,"eighty":-4.332713,"marketCap":16186714},{"date":"2023-01-27","current":-2.488006,"twenty":-15.134452,"median":-8.999523,"eighty":-4.281096,"marketCap":17495934},{"date":"2023-02-03","current":-2.547244,"twenty":-15.061324,"median":-8.939785,"eighty":-4.234421,"marketCap":17912503},{"date":"2023-02-10","current":-2.377992,"twenty":-14.980795,"median":-8.912362,"eighty":-4.200782,"marketCap":16722304},{"date":"2023-02-17","current":-2.572378,"twenty":-14.909476,"median":-8.88494,"eighty":-4.07975,"marketCap":18089248},{"date":"2023-02-24","current":-2.538782,"twenty":-14.844896,"median":-8.819202,"eighty":-4.017157,"marketCap":17852994},{"date":"2023-03-03","current":-2.648795,"twenty":-14.786699,"median":-8.718288,"eighty":-3.831612,"marketCap":18626623},{"date":"2023-03-10","current":-2.488006,"twenty":-14.7336,"median":-8.624543,"eighty":-3.777961,"marketCap":17495934},{"date":"2023-03-17","current":-2.157964,"twenty":-14.643442,"median":-8.603064,"eighty":-3.688542,"marketCap":15175044},{"date":"2023-03-24","current":-2.127971,"twenty":-14.519701,"median":-8.554917,"eighty":-3.567825,"marketCap":14964125},{"date":"2023-03-31","current":-2.315232,"twenty":-14.463957,"median":-8.486299,"eighty":-3.391222,"marketCap":16280968},{"date":"2023-04-06","current":-1.979013,"twenty":-14.378658,"median":-8.403234,"eighty":-3.335336,"marketCap":13916636},{"date":"2023-04-14","current":-1.966245,"twenty":-14.287498,"median":-8.311435,"eighty":-3.154494,"marketCap":13826851},{"date":"2023-04-21","current":-1.907234,"twenty":-14.209652,"median":-8.249563,"eighty":-2.791565,"marketCap":13168430},{"date":"2023-04-28","current":-1.892843,"twenty":-14.052638,"median":-8.158239,"eighty":-2.73978,"marketCap":13069068},{"date":"2023-05-05","current":-1.187686,"twenty":-13.914167,"median":-8.083856,"eighty":-2.69968,"marketCap":8200340},{"date":"2023-05-12","current":-0.679495,"twenty":-13.712693,"median":-7.963612,"eighty":-2.682794,"marketCap":4691552},{"date":"2023-05-19","current":-1.035296,"twenty":-13.580704,"median":-7.870301,"eighty":-2.589574,"marketCap":7148163},{"date":"2023-05-26","current":-0.878958,"twenty":-13.460618,"median":-7.865587,"eighty":-2.570177,"marketCap":6068737},{"date":"2023-06-02","current":-0.890678,"twenty":-13.412897,"median":-7.788843,"eighty":-2.562883,"marketCap":6149654},{"date":"2023-06-07","current":-0.891264,"twenty":-13.379485,"median":-7.750301,"eighty":-2.551939,"marketCap":6153699},{"date":"2023-06-15","current":-0.846378,"twenty":-13.234305,"median":-7.6805,"eighty":-2.544965,"marketCap":5843789},{"date":"2023-06-23","current":-0.978573,"twenty":-13.163346,"median":-7.611749,"eighty":-2.520854,"marketCap":6756527},{"date":"2023-06-30","current":-0.870169,"twenty":-13.029994,"median":-7.521467,"eighty":-2.513394,"marketCap":6008050},{"date":"2023-07-07","current":-0.902397,"twenty":-12.943419,"median":-7.472673,"eighty":-2.504275,"marketCap":6230570},{"date":"2023-07-14","current":-0.972714,"twenty":-12.889745,"median":-7.435218,"eighty":-2.488006,"marketCap":6716069},{"date":"2023-07-21","current":-0.892153,"twenty":-12.803082,"median":-7.349407,"eighty":-2.465674,"marketCap":6149654},{"date":"2023-07-28","current":-0.933239,"twenty":-12.729177,"median":-7.31323,"eighty":-2.440772,"marketCap":6432861},{"date":"2023-08-04","current":-0.987238,"twenty":-12.617531,"median":-7.225926,"eighty":-2.428809,"marketCap":6805077},{"date":"2023-08-11","current":-1.197364,"twenty":-12.500813,"median":-7.101059,"eighty":-2.42134,"marketCap":8253483},{"date":"2023-08-18","current":-1.220842,"twenty":-12.383388,"median":-7.064426,"eighty":-2.41243,"marketCap":8415316},{"date":"2023-08-25","current":-1.279536,"twenty":-12.336572,"median":-6.955491,"eighty":-2.398735,"marketCap":8819898},{"date":"2023-09-01","current":-1.232463,"twenty":-12.11462,"median":-6.875913,"eighty":-2.387237,"marketCap":8495423},{"date":"2023-09-08","current":-1.013064,"twenty":-12.086798,"median":-6.828681,"eighty":-2.377992,"marketCap":6983093},{"date":"2023-09-15","current":-1.115428,"twenty":-11.968099,"median":-6.668826,"eighty":-2.370742,"marketCap":7688693},{"date":"2023-09-22","current":-1.079975,"twenty":-11.813295,"median":-6.618092,"eighty":-2.362271,"marketCap":7444318},{"date":"2023-09-29","current":-1.138669,"twenty":-11.717442,"median":-6.542848,"eighty":-2.353044,"marketCap":7848900},{"date":"2023-10-06","current":-1.198664,"twenty":-11.638981,"median":-6.520681,"eighty":-2.340161,"marketCap":8262448},{"date":"2023-10-13","current":-1.276707,"twenty":-11.526163,"median":-6.499819,"eighty":-2.320472,"marketCap":8800396},{"date":"2023-10-20","current":-1.407128,"twenty":-11.488271,"median":-6.473736,"eighty":-2.310478,"marketCap":9699395},{"date":"2023-10-27","current":-1.459244,"twenty":-11.407561,"median":-6.454631,"eighty":-2.307051,"marketCap":10058632},{"date":"2023-11-03","current":-1.863141,"twenty":-11.200524,"median":-6.416353,"eighty":-2.296343,"marketCap":12842718},{"date":"2023-11-10","current":-2.221231,"twenty":-11.072124,"median":-6.374521,"eighty":-2.286817,"marketCap":15311046},{"date":"2023-11-17","current":-1.966568,"twenty":-10.97961,"median":-6.351632,"eighty":-2.246358,"marketCap":13555640},{"date":"2023-11-24","current":-2.019895,"twenty":-10.923124,"median":-6.324753,"eighty":-2.211171,"marketCap":13462399},{"date":"2023-12-01","current":-2.312857,"twenty":-10.83906,"median":-6.280532,"eighty":-2.210358,"marketCap":15414961},{"date":"2023-12-08","current":-2.220343,"twenty":-10.797412,"median":-6.231466,"eighty":-2.210358,"marketCap":14798363},{"date":"2023-12-15","current":-2.143248,"twenty":-10.687142,"median":-6.201269,"eighty":-2.187213,"marketCap":14284530},{"date":"2023-12-22","current":-2.066153,"twenty":-10.612428,"median":-6.179172,"eighty":-2.171698,"marketCap":13770698},{"date":"2023-12-29","current":-1.973638,"twenty":-10.596958,"median":-6.140861,"eighty":-2.157964,"marketCap":13154100},{"date":"2024-01-05","current":-2.143248,"twenty":-10.573585,"median":-6.117977,"eighty":-2.139346,"marketCap":14284530},{"date":"2024-01-12","current":-2.343696,"twenty":-10.462732,"median":-6.097421,"eighty":-2.131306,"marketCap":15620494},{"date":"2024-01-19","current":-2.742435,"twenty":-10.414921,"median":-6.060406,"eighty":-2.131152,"marketCap":16696705},{"date":"2024-01-26","current":-2.530945,"twenty":-10.363099,"median":-6.025016,"eighty":-2.131306,"marketCap":15409096},{"date":"2024-02-02","current":-2.721633,"twenty":-10.341251,"median":-6.014533,"eighty":-2.131306,"marketCap":16570056},{"date":"2024-02-09","current":-3.293696,"twenty":-10.266818,"median":-5.973923,"eighty":-2.131306,"marketCap":20052934},{"date":"2024-02-16","current":-4.091117,"twenty":-10.224822,"median":-5.937004,"eighty":-2.131306,"marketCap":24907855},{"date":"2024-02-23","current":-5.054829,"twenty":-10.196036,"median":-5.895319,"eighty":-2.131306,"marketCap":30775207},{"date":"2024-03-01","current":-7.68245,"twenty":-10.148328,"median":-5.877884,"eighty":-2.131461,"marketCap":46772892},{"date":"2024-03-08","current":-10.165167,"twenty":-10.086448,"median":-5.877884,"eighty":-2.131461,"marketCap":61888365},{"date":"2024-03-15","current":-7.827179,"twenty":-10.040038,"median":-5.877884,"eighty":-2.131461,"marketCap":47654041},{"date":"2024-03-22","current":-6.993635,"twenty":-9.962688,"median":-5.877884,"eighty":-2.131461,"marketCap":42579195},{"date":"2024-03-28","current":-7.542554,"twenty":-9.935991,"median":-5.877884,"eighty":-2.131461,"marketCap":45921166},{"date":"2024-04-05","current":-6.63909,"twenty":-9.90079,"median":-5.861912,"eighty":-2.131306,"marketCap":40420623},{"date":"2024-04-12","current":-5.945755,"twenty":-9.870325,"median":-5.861912,"eighty":-2.131306,"marketCap":32343039},{"date":"2024-04-19","current":-5.32986,"twenty":-9.807988,"median":-5.814067,"eighty":-2.131306,"marketCap":28992764},{"date":"2024-04-26","current":-5.18773,"twenty":-9.748753,"median":-5.782168,"eighty":-2.131461,"marketCap":28219623},{"date":"2024-05-03","current":-7.10648,"twenty":-9.715167,"median":-5.779641,"eighty":-2.131461,"marketCap":38657019},{"date":"2024-05-10","current":-8.527776,"twenty":-9.653288,"median":-5.779641,"eighty":-2.131461,"marketCap":46388422},{"date":"2024-05-17","current":-7.438116,"twenty":-9.622347,"median":-5.779641,"eighty":-2.131461,"marketCap":40461013},{"date":"2024-05-24","current":-6.822221,"twenty":-9.584217,"median":-5.779641,"eighty":-2.131461,"marketCap":37110738},{"date":"2024-05-31","current":-9.451618,"twenty":-9.560467,"median":-5.779641,"eighty":-2.131461,"marketCap":51413835},{"date":"2024-06-07","current":-8.077699,"twenty":-9.529527,"median":-5.779641,"eighty":-2.131461,"marketCap":43940144},{"date":"2024-06-14","current":-8.66286,"twenty":-9.498587,"median":-5.777581,"eighty":-2.131306,"marketCap":47123239},{"date":"2024-06-21","current":-7.583294,"twenty":-9.463548,"median":-5.770513,"eighty":-2.131152,"marketCap":41250738},{"date":"2024-06-28","current":-6.925022,"twenty":-9.421237,"median":-5.76339,"eighty":-2.130688,"marketCap":37669944},{"date":"2024-07-05","current":-6.951353,"twenty":-9.404254,"median":-5.76339,"eighty":-2.130688,"marketCap":37813176},{"date":"2024-07-12","current":-7.398978,"twenty":-9.312947,"median":-5.76339,"eighty":-2.130688,"marketCap":40248116},{"date":"2024-07-15","current":-9.095179,"twenty":-9.282007,"median":-5.76339,"eighty":-2.130688,"marketCap":44110471},{"date":"2024-08-02","current":-12.974484,"twenty":-9.187013,"median":-5.725627,"eighty":-2.124643,"marketCap":62924615},{"date":"2024-08-09","current":-10.790338,"twenty":-9.187013,"median":-5.725627,"eighty":-2.124643,"marketCap":52331778},{"date":"2024-08-16","current":-10.26875,"twenty":-9.187013,"median":-5.725627,"eighty":-2.124643,"marketCap":49802145},{"date":"2024-08-23","current":-9.87756,"twenty":-9.187013,"median":-5.725627,"eighty":-2.124643,"marketCap":47904921},{"date":"2024-08-30","current":-10.529544,"twenty":-9.187013,"median":-5.725627,"eighty":-2.124643,"marketCap":51066962},{"date":"2024-09-06","current":-10.757738,"twenty":-9.187013,"median":-5.725627,"eighty":-2.124643,"marketCap":52173676},{"date":"2024-09-13","current":-11.474921,"twenty":-9.187013,"median":-5.725627,"eighty":-2.124643,"marketCap":55651921},{"date":"2024-09-20","current":-10.26875,"twenty":-9.187013,"median":-5.725627,"eighty":-2.124643,"marketCap":49802145},{"date":"2024-09-27","current":-9.681965,"twenty":-9.187013,"median":-5.725627,"eighty":-2.124643,"marketCap":46956308},{"date":"2024-10-04","current":-10.790338,"twenty":-9.20682,"median":-5.725627,"eighty":-2.124643,"marketCap":52331778},{"date":"2024-10-11","current":-9.975358,"twenty":-9.214735,"median":-5.725627,"eighty":-2.124643,"marketCap":48379227},{"date":"2024-10-18","current":-9.225576,"twenty":-9.216122,"median":-5.725627,"eighty":-2.124643,"marketCap":44742880},{"date":"2024-10-25","current":-9.824086,"twenty":-9.213308,"median":-5.725627,"eighty":-2.124643,"marketCap":47645581},{"date":"2024-10-31","current":-8.168746,"twenty":-9.187013,"median":-5.725627,"eighty":-2.124643,"marketCap":39617388},{"date":"2024-11-08","current":-8.348674,"twenty":-9.105428,"median":-5.722197,"eighty":-2.123533,"marketCap":40490018},{"date":"2024-11-15","current":-7.628961,"twenty":-9.066105,"median":-5.722197,"eighty":-2.123533,"marketCap":36999499},{"date":"2024-11-22","current":-7.772904,"twenty":-9.020491,"median":-5.722197,"eighty":-2.123533,"marketCap":37697603},{"date":"2024-11-29","current":-6.263889,"twenty":-9.001137,"median":-5.722197,"eighty":-2.123533,"marketCap":36301395},{"date":"2024-12-06","current":-7.046875,"twenty":-9.001137,"median":-5.722197,"eighty":-2.123533,"marketCap":40839069},{"date":"2024-12-13","current":-6.805956,"twenty":-9.001137,"median":-5.722197,"eighty":-2.123533,"marketCap":39442862},{"date":"2024-12-20","current":-6.655382,"twenty":-9.001137,"median":-5.722197,"eighty":-2.123533,"marketCap":38570232},{"date":"2024-12-27","current":-7.137219,"twenty":-9.001137,"median":-5.722197,"eighty":-2.123533,"marketCap":41362647},{"date":"2025-01-03","current":-6.926415,"twenty":-9.001137,"median":-5.722197,"eighty":-2.123533,"marketCap":40140966},{"date":"2025-01-10","current":-6.655382,"twenty":-9.001541,"median":-5.722194,"eighty":-2.122424,"marketCap":38570232},{"date":"2025-01-17","current":-4.736024,"twenty":-8.999523,"median":-5.708343,"eighty":-2.122424,"marketCap":34666373},{"date":"2025-01-24","current":-4.364336,"twenty":-8.988077,"median":-5.687855,"eighty":-2.122424,"marketCap":31945721},{"date":"2025-01-31","current":-4.364336,"twenty":-8.953496,"median":-5.614061,"eighty":-2.122424,"marketCap":31945721},{"date":"2025-02-07","current":-4.532195,"twenty":-8.939785,"median":-5.573822,"eighty":-2.122424,"marketCap":33174402},{"date":"2025-02-14","current":-3.66892,"twenty":-8.895257,"median":-5.554362,"eighty":-2.122424,"marketCap":26855468},{"date":"2025-02-21","current":-3.429121,"twenty":-8.720404,"median":-5.505891,"eighty":-2.122424,"marketCap":25100209},{"date":"2025-02-28","current":-3.716879,"twenty":-8.66286,"median":-5.444257,"eighty":-2.122424,"marketCap":27206520},{"date":"2025-03-07","current":-3.309222,"twenty":-8.674369,"median":-5.376914,"eighty":-2.120821,"marketCap":24222579},{"date":"2025-03-14","current":-3.165343,"twenty":-8.674369,"median":-5.344313,"eighty":-2.120821,"marketCap":23169424},{"date":"2025-03-21","current":-3.788819,"twenty":-8.674369,"median":-5.316693,"eighty":-2.120821,"marketCap":27733098},{"date":"2025-03-28","current":-4.196477,"twenty":-8.674369,"median":-5.211418,"eighty":-2.120821,"marketCap":30717039},{"date":"2025-04-04","current":-3.66892,"twenty":-8.674369,"median":-5.166169,"eighty":-2.120821,"marketCap":26855468},{"date":"2025-04-11","current":-3.213302,"twenty":-8.66286,"median":-5.148914,"eighty":-2.122424,"marketCap":23520475},{"date":"2025-04-17","current":-2.619825,"twenty":-8.66286,"median":-5.027237,"eighty":-2.122424,"marketCap":24582850},{"date":"2025-04-25","current":-3.162503,"twenty":-8.674369,"median":-4.921084,"eighty":-2.120821,"marketCap":29675012},{"date":"2025-04-29","current":-2.28299,"twenty":-8.674369,"median":-4.895701,"eighty":-2.120821,"marketCap":21422198}],"updateTime":1746004465165}}}